Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Experimental Hematology & Oncology|December 10, 2013
Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparisonJames Signorovitch, Elyse Swallow, Evan Kantor, et al.The American Journal of Cardiology|March 29, 2023
Association of Serum Calcium and Phosphate With Incident Cardiovascular Disease in Patients With HypoparathyroidismSanjiv Kaul, Olulade Ayodele, Kristina Chen, et al.JAMA Dermatology|March 1, 2023
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured PopulationArash Mostaghimi, Wei Gao, Markqayne Ray, et al.Journal of Medical Economics|February 23, 2013
Medical resource use and costs associated with chylomicronemiaDaniel Gaudet, James Signorovitch, Elyse Swallow, et al.Journal of Medical Economics|January 6, 2022
The societal economic value of COVID-19 vaccines in the United StatesNoam Kirson, Elyse Swallow, Jessica Lu, et al.Journal of Managed Care & Specialty Pharmacy|March 25, 2022
All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United StatesArash Mostaghimi, Kavita Gandhi, Nicolae Done, et al.Expert Review of Hematology|May 14, 2025
Real-world treatment patterns and outcomes in people with von Willebrand disease treated prophylactically with recombinant von Willebrand factor in the United StatesJonathan C Roberts, Maissaa Janbain, Jessica R Marden, et al.Journal of Health Economics and Outcomes Research|August 17, 2022
Healthcare Utilization and Costs Among US Adolescents With Alopecia AreataMarkqayne Ray, Elyse Swallow, Kavita Gandhi, et al.Therapeutic Advances in Gastroenterology|May 8, 2023
Real-world outcomes associated with vonoprazan-based <i>versus</i> proton pump inhibitor-based therapy for <i>Helicobacter pylori</i> infection in JapanColin W Howden, Erin E Cook, Elyse Swallow, et al.Journal of Comparative Effectiveness Research|September 22, 2015
Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparisonElyse Swallow, Jinlin Song, Yong Yuan, et al.Pageof 7